Joseph Muenzer

Joseph Muenzer

(Chapel Hill, NC, USA)

Joseph Muenzer, MD, PhD is Professor of Pediatrics and Genetics in the Division of Genetics and Metabolism, Department of Pediatrics at the University of North Carolina at Chapel Hill, USA, where he has practiced since 1993. He is actively involved in the diagnosis, management and treatment of patients with inborn errors of metabolism, especially mucopolysaccharidosis (MPS) and infants detected by tandem mass spectrometry newborn screening. Dr Muenzer received his medical degree (1976) and PhD (Biochemistry, 1979) from Case Western Reserve University in Cleveland, Ohio. He completed his residency in pediatrics at the University of Wisconsin Hospital in Madison, and a genetics/endocrine fellowship at the National Institutes of Health in Bethesda, Maryland. Dr Muenzer is board certified in pediatrics and clinical biochemical/molecular genetics. Dr Muenzer’s clinical research is directed toward the development of enzyme replacement therapy (ERT) for MPS. He was a principal investigator for the recombinant enzyme replacement clinical trials for MPS I and MPS II. Dr Muenzer is currently a principal investigator for the Phase I/II and Phase II/III clinical trials evaluating intrathecal ERT for the severe form of Hunter syndrome and a Phase IIb intrathecal trial for MPS IIIA all sponsored by Shire.

>>back to faculty members<<   >>back to program<<

Developed by Doka35 | Web Studio.Hosted on Onde.ir